Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphomatoid Papulosis 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Disease 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

fludarabine phosphate 15Cyclophosphamide 15Peripheral Blood Stem Cell Transplantation 13Cyclosporine 12Whole-Body Irradiation 10Filgrastim 10Mycophenolic Acid 9Busulfan 8Antilymphocyte Serum 7Radiotherapy 5Methylprednisolone 5Melphalan 5Therapeutics 4Psychiatric Rehabilitation 4Methotrexate 4Exercise 4Etoposide 4Cord Blood Stem Cell Transplantation 4Blood Specimen Collection 4fludarabine 3Rituximab 3Prednisone 3Granulocyte Colony-Stimulating Factor 3Dexamethasone 3Aprepitant 3Analgesia 3plerixafor 2Tacrolimus 2Standard of Care 2Ondansetron 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Follicular × Bexarotene × Clear all
NCT05106192 2025-06-12

Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.

Case Comprehensive Cancer Center

Phase NA Withdrawn
DermatologicLymphoid

Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphomatoid Papulosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡